78 results
Page 2 of 4
8-K
EX-99.1
rwt82e7 z6n
9 Nov 22
Arcturus Therapeutics Announces Third Quarter 2022 Financial Update and Pipeline Progress
4:06pm
8-K
55vk2g 6agmwrwtm2jae
1 Nov 22
Arcturus Announces Collaboration with CSL to Develop and Commercialize Self-amplifying mRNA Vaccines
6:36pm
8-K
umh7lf1ono75234lybmn
1 Sep 22
Arcturus Announces $63.2 Million Award from the U.S. Government to Support Development of
5:09pm
8-K
EX-99.1
iet3b oy2nw
1 Sep 22
Arcturus Announces $63.2 Million Award from the U.S. Government to Support Development of
5:09pm
8-K
EX-99.1
3vk21ftyz5kd1w854g4j
9 Aug 22
Arcturus Therapeutics Announces Second Quarter 2022 Financial Update and Pipeline Progress
12:00am
8-K
EX-99.1
t54xs97
9 May 22
Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress
4:20pm
8-K
EX-99.1
3pc92n3867 1bo
28 Feb 22
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Update and Pipeline Progress
4:15pm
8-K
EX-14.1
viwywl9wp4zwy fx
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
8-K
EX-99.1
q8pt5d
8 Nov 21
Arcturus Therapeutics Announces Third Quarter 2021 Financial Update and Pipeline Progress
4:18pm
8-K
jeh 0s9q4tad
5 Oct 21
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-99.1
y0qlp
9 Aug 21
Arcturus Therapeutics Announces Second Quarter 2021 Financial Results and mRNA Vaccine and Therapeutics Pipeline Progress
4:02pm
8-K
EX-99.1
t2pzm
10 May 21
Arcturus Therapeutics Announces First Quarter 2021 Company Overview and Financial Results and Provides New Clinical Data
4:21pm
8-K
EX-99.1
5lebdk0j24uhy1
1 Mar 21
Arcturus Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Positive Clinical Updates
4:20pm